Physiomics (PYC)

Sector:

Health Care

Index:

FTSE AIM All-Share

 0.52p
   
  • Change Today:
      0.000p
  • 52 Week High: 0.70
  • 52 Week Low: 0.27
  • Currency: UK Pounds
  • Shares Issued: 453.21m
  • Volume: 555,878
  • Market Cap: £2.33m
  • RiskGrade: 504
  • Beta: 0.01

Physiomics Overview

Physiomics’ vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -58.4% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 2.8 n/a
Pr/Book 3.2  
Latest F'cast
Revenue 44.3% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Physiomics Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-21 0.70 (0.34) (0.22)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.83 (0.36) (0.26)p n/a n/a n/a n/a 0.0%
30-Jun-23 0.60 (0.57) (0.49)p n/a n/a n/a n/a 0.0%
30-Jun-24 0.54 (0.67) (0.45)p n/a n/a n/a n/a 0.0%
30-Jun-25 0.78 (0.46) (0.17)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Physiomics Company Announcements

Holding(s) in Company 26-Aug-2026 10:00 RNS
Holding(s) in Company 21-Aug-2026 16:12 RNS
Director/PDMR Shareholding 14-Jul-2026 07:00 RNS

Physiomics ShareCast News

Physiomics reports strong operational progress 26-Jun-2026 ShareCast
Physiomics reports strong operational progress 26-Jun-2026 ShareCast
New Physiomics board launches wide-ranging compa... 08-May-2026 ShareCast

Latest Physiomics Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Physiomics Market Data

Currency UK Pounds
Share Price 0.52p
Change Today 0.000p
% Change 0.00 %
52 Week High 0.70
52 Week Low 0.27
Volume 555,878
Shares Issued 453.21m
Market Cap £2.33m
Beta 0.01
RiskGrade 504

Physiomics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.89% below the market average22.89% below the market average22.89% below the market average22.89% below the market average22.89% below the market average
27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average27.27% below the sector average
Price Trend
71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Income Not Available
Growth
54.04% below the market average54.04% below the market average54.04% below the market average54.04% below the market average54.04% below the market average
82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average

Physiomics Dividends

No dividends found

Trades for 01-Sep-2026

Time Volume / Share Price
11:36 247,085 @ 0.48p
08:55 182,472 @ 0.48p
08:52 49 @ 0.48p
08:25 126,172 @ 0.48p
08:23 100 @ 0.52p

Physiomics Key Personnel

COO Jesse Thissen

Top of Page